Clinical Trial Update: A Study to Evaluate Immunotherapy Combinations in Participants With Gastrointestinal Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating immunotherapy combinations in gastrointestinal cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastroesophageal Cancer

Snippet

Sponsor: Arcus Biosciences, Inc. | Conditions: GastroEsophageal Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED